5IGV
Macrolide 2'-phosphotransferase type II - complex with GDP and azithromycin
Experimental procedure
Experimental method | MAD |
Source type | SYNCHROTRON |
Source details | CLSI BEAMLINE 08ID-1 |
Synchrotron site | CLSI |
Beamline | 08ID-1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2011-02-23 |
Detector | RAYONIX MX-300 |
Wavelength(s) | 0.9793 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 40.230, 80.450, 96.430 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 41.360 - 1.550 |
R-factor | 0.179 |
Rwork | 0.178 |
R-free | 0.20900 |
Structure solution method | FOURIER SYNTHESIS |
Starting model (for MR) | 5iwu |
RMSD bond length | 0.009 |
RMSD bond angle | 1.128 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHENIX |
Refinement software | PHENIX (1.10PRE_2104) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 41.356 | 1.590 |
High resolution limit [Å] | 1.550 | 1.550 |
Rmerge | 0.038 | 0.640 |
Number of reflections | 46230 | |
<I/σ(I)> | 30.01 | 3.59 |
Completeness [%] | 100.0 | 100 |
Redundancy | 8.1 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 7.5 | 295 | 0.1 M calcium acetate, 0.1M Tris, 25-40% PEG 4000 |